Kaisa Health Group Holdings Limited (0876.HK) Stock

About Kaisa Health Group Holdings Limited

Kaisa Health Group Holdings Limited, an investment holding company, engages in the health care and dental business in the People's Republic of China and internationally. It produces and sells dental prosthetics, including crowns and bridges, removable full and partial dentures, implants, and full-cast restorations, as well as provides sport rehabilitation services comprising postoperative rehabilitation, sports injury rehabilitation, chronic pain, scoliosis, deformity correction, and other rehabilitation services; and health leisure services. The company is also involved in the investment holding of loan receivable; provision of medical consultation and other medical services; and trading and provision of medical technology development. In addition, it trades in dental prosthetics, implant instruments, and other dental products. The company was formerly known as Mega Medical Technology Limited and changed its name to Kaisa Health Group Holdings Limited in January 2018. Kaisa Health Group Holdings Limited was founded in 1971 and is headquartered in Central, Hong Kong.

Kaisa Health Group Holdings Limited is led by CEO Jun Luo, employs 825 people, headquartered in Hong Kong, HK, publicly traded since 2005.

over the past 52 weeks the stock has ranged between $0.95 and $10.95, and currently trades 79.8% below its 52-week high.

Official website: www.kaisahealth.com